• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与离去基团亚位点S1'-S3'相互作用的胰凝乳蛋白酶的延长结合抑制剂。

Extended binding inhibitors of chymotrypsin that interact with leaving group subsites S1'-S3'.

作者信息

Imperiali B, Abeles R H

机构信息

Graduate Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02254.

出版信息

Biochemistry. 1987 Jul 14;26(14):4474-7. doi: 10.1021/bi00388a044.

DOI:10.1021/bi00388a044
PMID:3663602
Abstract

We have synthesized inhibitors of chymotrypsin, based on fluoromethyl ketones, that bind at S and S' subsites. "Small" inhibitors of serine proteases, which have previously been synthesized, only interact with S subsites. The parent compound is Ac-Leu-ambo-Phe-CF2H (1) (Ki = 25 X 10(-6) M). This inhibitor was modified by successively replacing H of the -CF2H group by -CH2CH2CONHCH3, (4), -CH2CH2CONH-Leu-NHMe (5), -CH2CH2CONH-Leu-Val-OEt (6), and -CH2CH2CONH-Leu-Arg-OMe (7). Corresponding Ki values are 7.8 (4), 0.23 (5), 0.21 (6), and 0.014 (7) microM. Extending 5 to 6 by addition of Val-OEt at P3' does not decrease Ki. In contrast, extension of 5 to 7 by incorporating Arg-OMe at P3' decreases Ki approximately 15-fold, suggesting interaction between Arg and the S3' subsite but no corresponding interaction at that subsite with Val. These results are in accordance with results obtained with the homologous family of avian ovomucoid third domain proteins. Proteins with Arg at the P3' position show highly favorable interactions with the protease at the S3' subsite [Park, S. J. (1985) Ph.D. Thesis, Purdue University; M. Laskowski, Jr., personal communication]. These results establish that incorporation of residues which interact with S' subsites significantly increases the efficacy of inhibitors and that valuable information concerning the most effective amino acid composition of small inhibitors can be obtained from the amino acid sequence of protein inhibitors.

摘要

我们基于氟甲基酮合成了胰凝乳蛋白酶抑制剂,这些抑制剂结合在S和S'亚位点。先前合成的丝氨酸蛋白酶“小型”抑制剂仅与S亚位点相互作用。母体化合物是Ac-Leu-ambo-Phe-CF2H(1)(Ki = 25×10⁻⁶ M)。通过依次将-CF2H基团的H替换为-CH2CH2CONHCH3(4)、-CH2CH2CONH-Leu-NHMe(5)、-CH2CH2CONH-Leu-Val-OEt(6)和-CH2CH2CONH-Leu-Arg-OMe(7)对该抑制剂进行修饰。相应的Ki值分别为7.8(4)、0.23(5)、0.21(6)和0.014(7)μM。在P3'处添加Val-OEt将5扩展为6并不会降低Ki。相反,在P3'处并入Arg-OMe将5扩展为7会使Ki降低约15倍,这表明Arg与S3'亚位点之间存在相互作用,但在该亚位点与Val没有相应的相互作用。这些结果与禽卵类粘蛋白第三结构域蛋白同源家族获得的结果一致。在P3'位置含有Arg的蛋白质在S3'亚位点与蛋白酶显示出非常有利的相互作用[Park, S. J. (1985) 博士论文,普渡大学;M. Laskowski, Jr.,个人交流]。这些结果表明,并入与S'亚位点相互作用的残基会显著提高抑制剂的效力,并且可以从蛋白质抑制剂的氨基酸序列中获得有关小型抑制剂最有效氨基酸组成的有价值信息。

相似文献

1
Extended binding inhibitors of chymotrypsin that interact with leaving group subsites S1'-S3'.与离去基团亚位点S1'-S3'相互作用的胰凝乳蛋白酶的延长结合抑制剂。
Biochemistry. 1987 Jul 14;26(14):4474-7. doi: 10.1021/bi00388a044.
2
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.猫免疫缺陷病毒(FIV)蛋白酶S3和S3'亚位点特异性分析:一种对FIV、SIV和HIV在体外和体内均有效的广谱蛋白酶抑制剂的研发。
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):939-44. doi: 10.1073/pnas.95.3.939.
3
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.人免疫缺陷病毒-1蛋白酶的羟乙烯电子等排体抑制剂:利用酶动力学、X射线晶体学和感染T细胞试验进行的构效关系分析
Biochemistry. 1992 Jul 28;31(29):6646-59. doi: 10.1021/bi00144a004.
4
Inhibition of serine proteases by peptidyl fluoromethyl ketones.肽基氟甲基酮对丝氨酸蛋白酶的抑制作用。
Biochemistry. 1986 Jul 1;25(13):3760-7. doi: 10.1021/bi00361a005.
5
Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.三价凝血酶抑制剂P1'和P3'残基的设计及其晶体结构
Biochemistry. 2000 Mar 7;39(9):2384-91.
6
Inhibition of chymotrypsin by fluorinated alpha-keto acid derivatives.氟化α-酮酸衍生物对胰凝乳蛋白酶的抑制作用。
Biochemistry. 1992 Oct 6;31(39):9429-35. doi: 10.1021/bi00154a015.
7
Inhibition of human leukocyte elastase by N-substituted peptides containing alpha,alpha-difluorostatone residues at P1.P1位含有α,α-二氟代甾酮残基的N-取代肽对人白细胞弹性蛋白酶的抑制作用
J Med Chem. 1992 Dec 25;35(26):4795-808. doi: 10.1021/jm00104a004.
8
Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.α-裂解蛋白酶和人白细胞弹性蛋白酶的氟代酮抑制剂的构效关系研究。
Arch Biochem Biophys. 1990 Jul;280(1):137-46. doi: 10.1016/0003-9861(90)90528-7.
9
New thiol inhibitor of Achromobacter iophagus collagenase. Specificity of the enzyme's S3' subsite.食油无色杆菌胶原酶的新型硫醇抑制剂。该酶S3'亚位点的特异性。
Eur J Biochem. 1986 Oct 15;160(2):413-8. doi: 10.1111/j.1432-1033.1986.tb09987.x.
10
The specificity of prolyl endopeptidase from Flavobacterium meningoseptum: mapping the S' subsites by positional scanning via acyl transfer.脑膜炎败血黄杆菌脯氨酰内肽酶的特异性:通过酰基转移的位置扫描绘制S'亚位点图谱。
Bioorg Med Chem. 1998 Oct;6(10):1775-80. doi: 10.1016/s0968-0896(98)00145-x.

引用本文的文献

1
Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles.肽基 α-酮酰胺和 α-酮杂环对诺如病毒 3CL 蛋白酶的强效抑制作用。
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4820-6. doi: 10.1016/j.bmcl.2012.05.055. Epub 2012 May 26.
2
Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.基于1,2,5-噻二唑烷-3-酮1,1-二氧化物的磺酰胺类化合物对人中性粒细胞弹性蛋白酶的失活作用
Bioorg Med Chem. 2008 Jan 15;16(2):692-8. doi: 10.1016/j.bmc.2007.10.041. Epub 2007 Oct 18.
3
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
主要位点占据对丙型肝炎病毒NS3蛋白酶结构的影响。
Protein Sci. 2002 Sep;11(9):2102-12. doi: 10.1110/ps.0206602.
4
Inhibitors of human heart chymase based on a peptide library.基于肽库的人心脏糜酶抑制剂
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6738-42. doi: 10.1073/pnas.92.15.6738.
5
Synthesis and properties of peptidyl derivatives of arginylfluoromethanes.精氨酰氟甲烷的肽基衍生物的合成与性质
Biochem J. 1988 Dec 1;256(2):481-6. doi: 10.1042/bj2560481.